Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

BACKGROUND: The humanized anti-CGRP monoclonal antibody eptinezumab has been evaluated in five large-scale clinical trials conducted in patients with migraine. This integrated analysis was conducted to evaluate the comprehensive safety and tolerability of eptinezumab in patients with migraine across...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Headache Pain
Main Authors: Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Schaeffler, Barbara, Shen, Vivienne, Sperling, Bjørn, Brevig, Thomas, Josiassen, Mette Krog, Brunner, Elizabeth, Honeywell, Loan, Mehta, Lahar
Formato: Artigo
Idioma:Inglês
Publicado: Springer Milan 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8008612/
https://ncbi.nlm.nih.gov/pubmed/33781209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-021-01227-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares